Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,559 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT01714466 | Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy | completed | Phase 2 | 240 | NorgineINDUSTRY | 1 | Nov 20, 2014 |
| clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00393822 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | completed | Phase 2 / Phase 3 | 100 | AmgenINDUSTRY | 0 | Jul 15, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00675012 | NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 24 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 53 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01116687 | RO4929097 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00504153 | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 19, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT00035087 | EPO906 Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 62 | Novartis PharmaceuticalsINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00026234 | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00005818 | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00041340 | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT01042743 | Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial | completed | Phase 2 | 80 | Kyungpook National University HospitalOTHER | 1 | Dec 20, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00193167 | Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00063427 | Study Evaluating MAC-321 in Colorectal Cancer | completed | Phase 2 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00072748 | Study Evaluating EKB-569 in Advanced Colorectal Cancer | completed | Phase 2 | 63 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00018551 | Chemoprevention With Folic Acid | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 300 | Mast Therapeutics, Inc.INDUSTRY | 5 | Aug 25, 2008 | clinicaltrials |
| NCT00001805 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00081627 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 48 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 27, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Jan 6, 2015source: clinicaltrials